Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESC-HBR: De-escalation of Antiplatelet Therapy in HBR Patients
NCT05903976Phase 3Unknown
- Sponsor
- Azienda Ospedaliera Universitaria Gaetano Martino
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel, prasugrel, ticagrelor in acute coronary syndrome (ACS), coronary artery disease (CAD), sponsored by Azienda Ospedaliera Universitaria Gaetano Martino. Status: unknown.
02
Drugs
clopidogrelprasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05903976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903976.